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Abstract
Overlap between non-coding DNA regulatory sequences and common variant associations
can help to identify specific cell and tissue types that are relevant for particular diseases. In
a systematic manner, we analyzed variants from 94 genome-wide association studies
(reporting at least 12 loci at p<5x10-8) by projecting them onto 466 epigenetic datasets
(characterizing DNase I hypersensitive sites; DHSs) derived from various adult and fetal tis-
sue samples and cell lines including many biological replicates. We were able to confirm
many expected associations, such as the involvement of specific immune cell types in
immune-related diseases and tissue types in diseases that affect specific organs, for exam-
ple, inflammatory bowel disease and coronary artery disease. Other notable associations
include adrenal glands in coronary artery disease, the immune system in Alzheimer’s dis-
ease, and the kidney for bone marrow density. The association signals for some GWAS (for
example, myopia or age at menarche) did not show a clear pattern with any of the cell or tis-
sue types studied. In general, the identified variants from GWAS tend to be located outside
coding regions. Altogether, we have performed an extensive characterization of GWAS sig-
nals in relation to cell and tissue-specific DHSs, demonstrating a key role for regulatory
mechanisms in common diseases and complex traits.
Introduction
In the last decade, genome-wide association studies (GWAS) identified a plethora of single
nucleotide polymorphisms (SNPs) robustly associated to various quantitative traits and com-
plex diseases [1]. Interestingly, the vast majority of these SNPs are located outside of coding
regions and do not affect the primary sequence of protein coding genes [1]. Due to linkage dis-
equilibrium in the human genome, however, these SNPs should be considered as markers for
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nearby functional variants, including those that affect protein sequence as well as those that
influence gene expression [2, 3]. Indeed, further fine-mapping of association peaks from
GWAS is required for a complete understanding of genotype-phenotype correlations, espe-
cially for broad associated regions harboring multiple genes.
Each cell type in the human body has a unique set of regulatory regions and the cumulative
span of those regions comprises as much as 80% of the non-coding DNA [4]. The plasticity
and variability of active regulatory regions can be exploited for the identification of cell or tis-
sue types that play a key role in the etiology of a given disease [3]. An excess overlap between
variants associated with a human disease or a phenotypic trait and regulatory DNA sequence
elements can thus point to “critical” cell type(s) that may play a causal role in the disease. This
has been recently demonstrated for a limited number of diseases using histone H3 lysine 4 tri-
methylation (H3K4me3) chromatin immunoprecipitation (ChIP) and DNase I hypersensitive
sites (DHSs) as readouts for cell-specific regulatory regions[3, 5–7]. Even though several stud-
ies have demonstrated the potential value of this approach, an extensive annotation of larger
number of cell types or tissues against the catalog of genome-wide association results is still
lacking.
Here we followed up on this idea in a systematic way. We tested all bona fide variants associ-
ated with diseases and traits from 94 different studies for excess overlap with DHSs assayed in
124 different cell types by the ENCODE consortium[4] and in 342 various adult end fetal tissue
samples assayed for DHSs by the NIH Roadmap Epigenomics Project[8]. We report many
known and novel associations between tissue and cell types and diseases.
Results
Datasets
To systematically annotate different GWAS loci with known regulatory elements we accessed
the results of 2101 different GWAS from the NHGRI GWAS Catalog [9]. To increase the sta-
tistical power and the specificity of our analysis, we selected only GWAS with at least 12 inde-
pendent loci each achieving genome-wide significance at a p-value < 5 x 10−8; altogether, we
included the results from 94 GWAS for our study (S1 Table). Next, we downloaded 466 DHS
datasets produced by the ENCODE consortium[10] or by the NIH Roadmap Epigenomics
Project[8] (S2 Table). On average, the data comprised ~87,000 DHSs per tissue or cell type
(S1A Fig) spanning on average 25 million bases (S1B Fig) per sample, i.e. slightly less than 1%
of the human genome.
We have focused on these particular datasets, since DHSs are considered to be one of the
best discriminative features [6] between cell types. Even though chromatin mark H3K4me3
was shown to be slightly better in predicting “critical” cell types[6], we used DHSs since these
were available for a larger number of different cell types and tissues, and importantly, included
data for biological replicates (S1C and S1D Fig).
Strategy to associate regulatory elements with SNPs
In order to estimate the enrichment of overlap between genomic elements, we opted for a con-
servative model that is not sensitive to linkage disequilibrium amongst nearby SNPs. For each
independent SNP association peak from the GWAS, we counted the number of DHSs within a
500 kb wide region centered on the lead SNP (Fig 1). The model gives similar results with dif-
ferent region sizes (100, 250, 500 and 1000kb) (S2 Fig), while the 500kb wide region provides
the best compromise between sensitivity and specificity, especially for GWAS with smaller
number of associated loci. In addition a substantial part of distal chromatin interaction of pro-
moters with regulatory elements is within this distance[11]. We estimated the level of
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enrichment and the statistical significance from a null model where appropriately matched
SNP sets are also tested for overlap with the DHSs. The matched SNPs are selected in such a
way to have a similar distribution with respect to transcriptional start sites, minor allele fre-
quency [12] and similar number of genes in vicinity as the associated SNPs from the GWAS.
To demonstrate the reliability and reproducibility of our model we selected two different
GWASs that identified SNPs associated with renal function-related traits and inflammatory
bowel disease (IBD). Based on pathogenesis of these particular traits [13, 14] we expected to
find associations with specific cells/tissues (intestines, kidney and various immune cells). Each
tissue/cell type is represented by multiple DHS datasets derived from different individuals,
allowing us to explore the reproducibility of the model. We identified a significant enrichment
of DHS sites nearby the associated variants within the expected cell types compared to the null
model (Fig 2). The DHS from kidney exhibited the greatest enrichment in the vicinity of vari-
ants associated with renal function[15] (Average Fold Enrichment (AFE) = 1.45 +/- 0.08,
P = 0.026), while the DHS sites identified in leukocytes and intestinal tissue were the most
enriched sites for variants associated with IBD[16] (AFE = 1.34 +/- 0.11, P = 2x10-5 and
AFE = 1.19 +/- 0.04, P = 0.0061; respectively). Importantly, we observed low variability
between different replicates of the same tissue or cell type.
Systematic association
Having demonstrated the potential value of the approach, we systematically compared the
associations of the loci from 94 GWAS with 342 DHS from the NIH Roadmap Epigenomics
Consortium (Fig 3, S3 Fig and S3 Table) and 124 DHS from ENCODE consortium (S4 Fig and
S4 Table). This resulted in a total of 7,878 statistically significant associations between GWAS
variants and DHS datasets (P< 0.05).
We were able to confirm a large number of the expected and known associations. For exam-
ple, the association of DHS active in immune cells and variants linked to numerous immune-
related[17–20] diseases like inflammatory bowel disease (IBD) (AFE = 1.34 +/- 0.11, P = 2x10-5),
celiac disease (AFE = 1.64 +/- 0.29, P = 0.00027), type 1 diabetes (AFE = 1.29 +/- 0.15, P = 0.046)
and systemic lupus erythematosus (AFE = 1.53 +/- 0.30, P = 0.040) (Fig 4 and S2 and S3 Figs)
were the most prominent. Also, numerous organ-specific traits like renal function-related traits,
IBD or coronary heart disease showed overlaps between the associated genetic variants and
DHS that are known to be “open” in the affected organ (kidney (AFE = 1.45 +/- 0.08, P = 0.026),
intestine (AFE = 1.19 +/- 0.04, P = 0.0061) and heart (AFE = 1.55 +/- 0.05, P = 0.0016), respec-
tively; see Fig 4, S2 and S3 Figs).
Fig 1. Schematic description of the association model used to quantify the overlap between regulatory elements (black and red DHS peaks)
and disease-associated variants (SNP1, 2 and 3) in various cell types (cell type 1, 2 and 3). The model estimates the regulatory activity by
counting the number of DHS peaks (red) located within the region of a 500kb with the associated tag SNP in the middle.
doi:10.1371/journal.pone.0165893.g001
Extensive Association of Common Disease Variants with Regulatory Sequence
PLOS ONE | DOI:10.1371/journal.pone.0165893 November 22, 2016 3 / 12
Comparison of different GWAS groups
On the one hand, our results illustrate that numerous genetic variants associated with various
traits overlap with DHSs active in relevant cell types (Fig 3), in some cases concordant with
expectation. On the other hand, such DHS-cell type associations cannot be confirmed or
detected for all GWAS studied here (Fig 3).
To explore this phenomenon in more detail, we have divided the GWAS into three similarly
sized groups (green, orange and red group) based on the enrichment p-value of the most sig-
nificant DHS dataset. Green group consist of GWASs with the most significant p-value of the
DHS enrichment while the red group consist of the studies with the least significant p-value.
The orange group consists of GWASs with the intermediate p-value.
A negative result in some GWAS could potentially be explained by having too few bona fide
associations per study (trait), reducing the power to detect significant associations with tissue
or cell types. This is consistent with the GWAS in the red group having a lower number of
reported associations (Figs 3 and 5A) compared to the green group. Secondly, we explored if
GWASs in different groups are more or less enriched in coding variants as a possible explana-
tion for having poor association with regulatory regions. Interestingly, the percentage of tag
SNPs with coding potential (missense, nonsense, frame shift and splice site variants) was
higher in those GWASs that showed also more significant associations with non-coding regu-
latory regions (Fig 5B). The identified variants in all GWAS groups show similar average
Fig 2. Reproducibility of the quantification model. Parallel dot-plots depicting the enrichment over the null
distribution and the significance (p-value) between the regulatory elements active in selected tissues and cells
(defined by the DHS) with variants associated to renal function and IBD. Each point represents the separate
replicate of DHS assay in the given tissue.
doi:10.1371/journal.pone.0165893.g002
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minor allele frequencies (Fig 5C) and are equally likely to be located close to the annotated
transcriptional start sites (+/- 25kb) (Fig 5D). Finally, only 48% of the GWAS in the red group
had replication data, compared to 71% and 79% of the studies in the orange and green group,
respectively, based on information from the NHGRI GWAS Catalog [9] (Fig 3).
Notable associations
Although some associations implicating certain cell or tissue types were unsurprising given
known biology, we also observed several notable associations. For example, even though coro-
nary artery disease due to atherosclerosis is a progressive inflammatory disease characterized
by the accumulation of lipids, fibrous materials, and mineral in the arteries [21], loci identified
by GWAS for coronary artery disease show a strong association with regulatory regions that
are active in adrenal glands (AFE = 1.57 +/- 0.04, P = 0.00051) (Fig 4, S3 Fig and S3 Table).
Interestingly, increased levels of androgens secreted by adrenal glands [22], Cushing’s syn-
drome [23], sympatho-adrenal medullary activation [24], and neuroendocrine stress axis [25]
Fig 3. Systematic association of common variants identified by 94 different GWAS with open chromatin (DHS) in selected tissues and cells.
The individual GWAS are sorted based on the minimal association p-value with 466 DHS (only selected DHS samples are shown). Size of the dot
represents the enrichment over the null distribution and color of the dot represents the significance of the enrichment—with black being the most
significant. The bar graphs depict the number of associated SNPs (grey), the fraction of coding SNPs (red) and minor allele frequency (green).
Heatmap depicts the distribution of SNPs with respect to transcriptional start sites (intensity of blue depicts the fraction of SNPs within the distance
bin). Green/orange/white bar shows the presence of the replication cohort (green—present, white—no replication cohort as specified in the in NHGRI
GWAS Catalog) separately for each GWAS. Group bar depicts the annotation of GWAS to one of three “GWAS groups”. Green—GWAS with the best
association p-value < = 0.0001, orange < = 0.01 and red—GWAS with the best association p-value < 0.01.
doi:10.1371/journal.pone.0165893.g003
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are all strongly associated with adrenal glandular dysfunction and increased risk for coronary
heart disease. This provides some support for the adrenal glands as a potentially causal tissue
type in coronary artery disease, among other mechanisms—possibly through the impairment
of the action of the adrenal gland-secreted hormone adrenalin (epinephrine) resulting in
decreased coronary perfusion [26]. However, additional functional studies are warranted [27].
Next, our analysis suggests the possible involvement of immune system (AFE = 1.30 +/-
0.13 P = 0.088) in Alzheimer’s disease pathogenesis [28]. Links between Alzheimer’s disease
and local or systemic immunologic dysfunction have previously been described [29–31]. The
immune mechanisms and microglia are shown to be involved in the clearance of amyloid beta
peptide [32]. Also, the evidence from the retrospective studies shows that the levels of inflam-
matory proteins in plasma are increased even before the clinical onset of dementia [33]. Addi-
tionally, the inhibition of IL-12/IL-23 signaling—normally activated in response to a variety of
pathogens, was found to reduce Alzheimer’s disease-like pathology and cognitive decline [34].
These and our findings support a potential role of the immune system in Alzheimer’s disease.
Similarly, we found that the variants influencing bone mineral density were associated with
open regulatory regions in the kidney (AFE = 1.22 +/- 0.05, P = 0.033) (S2 Fig and S3 Table).
Interestingly, bone density regulation have been associated with renal function [35, 36]. Meta-
bolic bone disease is a common complication of chronic kidney disease (CKD) due to control
mechanisms for calcium and phosphorus homeostasis altered in CKD patients [37]. Again,
these findings illustrate that plausible connections can be inferred from the integration of
GWAS and epigenomic data, implicating potentially causal cell and tissue types for specific
diseases and traits.
Fig 4. Tissues and cell types associated with common variants identified by selected GWASs. Each point represents the separate replicate of
DHS assay in the given tissue.
doi:10.1371/journal.pone.0165893.g004
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Discussion
Here we provide an extensive characterization of the relation between open chromatin regions
from hundreds of cell and tissue samples and bona fide SNP associations from GWAS for vari-
ous human diseases and traits. Our results support the general idea that the etiology of com-
plex disease can originate from specific cell or tissue types. Indeed, our analyses identify
known and novel associations between complex diseases and specific cell and tissue types,
which can serve as a resource for further research.
Fig 5. Comparison of selected GWAS parameter between three GWAS groups. A) The number of
associated SNPs B) the fraction of coding SNPs C) minor allele frequency and D) the distribution of SNPs with
respect to transcriptional start sites (no line—non significant, * p-value < 0.05, ** p-value < 0.01, using
Wilcoxon signed-rank test), green—GWAS with the best association p-value < = 0.0001, orange < = 0.01 and
red—GWAS with the best association p-value < 0.01.
doi:10.1371/journal.pone.0165893.g005
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In many instances, GWAS variants show significant overlap with DHS sites from several
different cell and tissue types. While this may reinforce the complex nature of the traits stud-
ied, it does not rule out the scenario that genetic variants can alter the function of ubiquitously
active regulatory elements in a cell type specific manner under certain conditions [38], e.g.
after cell activation. Future studies that incorporate gene expression profiles [39] might pro-
vide more specific insight into the critical cell types.
While many GWAS showed overlap of identified variants and open chromatin regions in
relevant cell types, numerous GWAS showed weaker associations without any strong signal
implicating a specific cell or tissue type. Perhaps for these traits the underlying genetic mecha-
nisms might be different, or the relevant cell or tissue type was not present among the 466
DHS datasets evaluated. For some of these traits, we cannot exclude the possibility of multiple
cell types and tissues being involved, which would cause the association signal to be diluted
and to fall below the detection limit of our model.
In conclusion, we present an extensive association analysis between GWAS association sig-
nals and specific cell and tissue DHS sites, providing us with novel insights into underlying
mechanisms of common diseases and a useful resource for further analyses.
Materials and Methods
GWAS datasets
GWAS datasets were accessed from the NHGRI GWAS Catalog (http://www.genome.gov/
gwastudies/) [9] on at 2ndth February 2015. We included GWAS with at least 12 reported loci
at genome-wide significance (p<5 x 10−8) (S1 Table).
DHS datasets
DHS datasets derived from 124 cell lines [3] (S2 Table) were accessed at the http://ftp.ebi.ac.
uk/pub/databases/ensembl/encode/integration_data_jan2011/byDataType/openchrom/
jan2011/fdrPeaks/ on 31st July 2013.
DHS sequencing reads from 342 tissue samples produced by NIH Roadmap Epigenomics
Project [8] were accessed via the 9th release of Human Epigenome Atlas. Cisgenome v.2 [40]
software package (-e 50, -maxgap 200, -minlen 200) was used for peak-calling from the Road-
map Epigenomics datasets against the common input sample. All called peaks have false dis-
covery rate (FDR) < 0.05.
Association of DHS and GWAS loci
A susceptibility locus was defined as a 500-kb wide region centered on the reported SNP from
a GWAS. Neighboring SNPs reported by the GWAS were considered as a single locus. DHSs
were considered as overlapping with a susceptibility locus when at least one base overlapped
with the locus [12]. To calculate the enrichment of DHSs across susceptibility loci and to esti-
mate the p-value, we compared the observed number of DHSs overlapping the susceptibility
loci with the number of overlapping DHSs with 50,000 matched sets of random “null” loci.
These “null” loci were sampled from SNPs present on the Human Omni1S genotyping chip
(Illumina) with a similar minor allele frequency (+/- 5%) as the SNPs from the GWAS
included in this study (using frequencies from ftp://ftp.ensembl.org/pub/release-72/variation/
gvf/homo_sapiens/1000GENOMES-phase_1_EUR.gvf.gz). Next, we controlled for the non-
random physical distribution of the susceptibility loci with respect to annotated genes by sam-
pling only variants with similarly located closest annotated transcription start site as the SNPs
from the GWAS (using annotation files downloaded from the Cisgenome website [40]). To
Extensive Association of Common Disease Variants with Regulatory Sequence
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this end, we defined distinct location bins [−200 k bp, −100 k bp, −25 k bp, −10 k bp, −5 k bp,
0 bp, 5 k bp, 10 k bp, 25 k bp, 100 k bp, 200 k bp] relative to the closest transcription start site
(TSS). In addition, we have excluded those control SNPs that did not have similar number of
annotated TSS within 500kb from SNP location (0 to 9 or 10 to 24 or more than 24 TSS) as the
SNP from the GWAS.
Computational analysis of GWAS loci
The GWAS were assigned into 3 groups based on the best association p-value. Green—GWAS
with the best association p-value < = 0.0001, orange between >0.0001 and< = 0.01 and red—
GWAS with the best association p-value > 0.01.
The information about minor allele frequency (based on Utah residents with Northern and
Western European ancestry from the CEPH collection “CEU dataset”) for GWAS SNPs was
accessed from the HapMap website [41]: http://hapmap.ncbi.nlm.nih.gov/downloads/ld_data/
latest/ on 8th of August 2013.
The information about the potential impact of the SNP on protein product was accessed
from Ensembl Variation 75 database (Homo sapiens Short Variation, GrCh37.p13) [42] via
BioMart [43]. After manual inspection, all SNPs tagged as ‘missense_variant’, ‘splice_region_-
variant’, ‘frameshift_variant’, ‘stop_gained’, ‘stop_lost’, ‘feature_elongation’ or ‘splice_donor_-
variant’ for at least one annotated coding transcript were considered as SNPs with potential
impact on protein sequence.
The analysis was performed using custom Perl and R scripts together with the utilities from
Cisgenome[40].
Supporting Information
S1 Fig. Distribution of A) number of peaks and B) total base pairs covered in ENCODE
and Roadmap Epigenomics DHS samples and correlation heatmaps between different
DHS samples from ENCODE (C) and Roadmap Epigenomics (D).
(TIF)
S2 Fig. Reproducibility of the quantification model with different locus size (100, 250, 500
and 1000 kilobases). Parallel dot-plots depicting the enrichment over the null distribution
between the regulatory elements active in selected tissues and cells (defined by the DHS) with
variants associated to renal function and IBD. Each point represents the separate replicate of
DHS assay in the given tissue.
(TIF)
S3 Fig. Systematic association of common variants identified by 86 different GWAS with
open chromatin in 342 tissue samples. The GWAS are sorted based on the minimal associa-
tion p-value with 466 DHS tracks. Size of the dot represents the enrichment over the null dis-
tribution and color of the dot represents the significance of the enrichment—with black being
the most significant.
(TIF)
S4 Fig. Systematic association of common variants identified by 86 different GWAS with
open chromatin regions in 124 cell lines. The GWAS are sorted based on the minimal associ-
ation p-value with 466 DHS tracks. Size of the dot represents the enrichment over the null dis-
tribution and color of the dot represents the significance of the enrichment—with black being
the most significant.
(TIF)
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S1 Table. List of GWAS.
(XLS)
S2 Table. List of DHS datasets.
(XLS)
S3 Table. Results of Roadmap data.
(PDF)
S4 Table. Results of ENCODE data.
(PDF)
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